deltatrials
Unknown PHASE4 INTERVENTIONAL 2-arm NCT02601222

Efficacy and Safety of Runzao Zhiyang Capsule to Treat Chronic Eczema

A Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trials to Evaluate the Efficacy and Safety of Runzao Zhiyang Capsule in Treating Chronic Eczema

Sponsor: Beijing Bionovo Medicine Development Co., Ltd.

Conditions Chronic Eczema
Interventions Runzao zhiyang capsule Runzaozhiyang capsule agent simulation Urea cream
Updated 7 times since 2017 Last updated: Sep 19, 2016 Started: Mar 31, 2016 Primary completion: Dec 31, 2016 Completion: Feb 28, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Chronic Eczema and is currently ongoing. Beijing Bionovo Medicine Development Co., Ltd. leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotRecruiting~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshotRecruiting~Oct 2018 – ~Jan 2021 · 27 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown Status → Unknown

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE4

  5. Oct 2018 — Jan 2021 [monthly]

    Unknown Status PHASE4

    Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

  1. Jun 2018 — Oct 2018 [monthly]

    Recruiting PHASE4

  2. Jan 2017 — Jun 2018 [monthly]

    Recruiting PHASE4

    First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Beijing Bionovo Medicine Development Co., Ltd.
  • Guizhou Tongjitang Pharmaceutical Co.,Ltd
Data source: Guizhou Tongjitang Pharmaceutical Co.,Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations